New Paragraph IV Certifications as of May 22, 2018

DRUG NAME	DOSAGE FORM	STRENGTH	RLD	DATE OF SUBMISSION
Apremilast	Tablets	10 mg, 20 mg and 30 mg	Otezla, 205437	3/22/2018
Linagliptin and Metformin Hydrochloride	Extended-release Tablets	2.5 mg/1000 mg 5 mg/1000 mg	Jentadueto XR, 208026	3/28/2018
Tolvaptan	Tablets	60 mg	Samsca, 22275	3/26/2018

Click here to view full list of Paragraph IV Certificates filed as of April 25, 2018